Allurion Technologies (ALUR) Net Cash Flow Growth (3y) (2025 - 2026)

Allurion Technologies (ALUR) Net Cash Flow Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn -32.51%
2 Stryker 128.80 Bn 125.92 Bn 3.81 Bn -87.87%
3 Medtronic 108.82 Bn 99.60 Bn 6.41 Bn 31.32%
4 Boston Scientific 68.54 Bn 67.08 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 48.37 Bn 44.70 Bn 1.29 Bn -87.88%
6 Dexcom 28.41 Bn 27.30 Bn 750.30 Mn 129.29%
7 GE HealthCare Technologies 28.33 Bn 26.04 Bn 1.98 Bn -65.12%
8 Smith & Nephew 26.96 Bn 26.38 Bn - -
9 Koninklijke Philips 25.43 Bn 22.31 Bn 2.07 Bn -48.90%
10 Allurion Technologies 74.67 Mn 69.62 Mn 1.23 Mn -29.17%

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.17%
Dec 31, 2025 22.68%
Sep 30, 2025 -230.68%